Reviva Pharmaceuticals
RVPH
RVPH
23 hedge funds and large institutions have $46.1M invested in Reviva Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+2
Holders Change %
+9.52%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$3.47M |
| 2 |
GCL
Glazer Capital LLC
New York
|
+$1.05M |
| 3 |
CIM
Cowen Investment Management
New York
|
+$1.05M |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$678K |
| 5 |
MSU
Mizuho Securities USA
New York
|
+$398K |
